Management of hyperthyroidism during pregnancy in Asia

Endocrine Journal

Volumn 61, Issue 8, 2014, Pages 751-758

  Azizi, Fereidoun ^a   Amouzegar, Atieh ^a   Mehran, Ladan ^a   Sarvghadi, Farzaneh ^a   Alamdari, Shahram ^b   Subekti, Imam ^c   Vaidya, Bijay ^d   Poppe, Kris ^e   Luis, Teofilo San ^f   Akamizu, Takashi ^g  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^d ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^f UNIVERSITY OF SANTO TOMAS   (Philippines)

^g WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Hyperthyroidism; Management; Pregnancy

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; LIOTHYRONINE; PROPYLTHIOURACIL; THIAMAZOLE; THYROTROPIN; THYROTROPIN RECEPTOR; THYROXINE;

ARTICLE; ASIA; ASIAN; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MATERNAL HYPERTHYROIDISM; MEDICAL SOCIETY; PRACTICE GUIDELINE; PREGNANCY; PREGNANT WOMAN; QUESTIONNAIRE; SUBCLINICAL HYPERTHYROIDISM; THYROTOXICOSIS; ADULT; INFORMATION PROCESSING; PATIENT REFERRAL; PREGNANCY COMPLICATIONS; PROFESSIONAL PRACTICE; PUERPERIUM; STATISTICS AND NUMERICAL DATA; THYROID FUNCTION TEST; YOUNG ADULT;

ADULT; ASIA; DATA COLLECTION; FEMALE; HUMANS; HYPERTHYROIDISM; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; PROFESSIONAL PRACTICE; PROPYLTHIOURACIL; QUESTIONNAIRES; REFERRAL AND CONSULTATION; THYROID FUNCTION TESTS; YOUNG ADULT;

EID: 84906835296     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ14-0145     Document Type: Article

References (37)

1. Azizi F, Amouzegar A (2011) Management of hyperthyroidism during pregnancy and lactation. Eur J Endocrinol 164: 871-876.
2. Tan JY, Loh KC, Yeo GS, Chee YC (2002) Transient hyperthyroidism of hyperemesis gravidarum. BJOG 109: 683-688.
3. Stagnaro-Green A (2009) Maternal thyroid disease and preterm delivery. J Clin Endocrinol Metab 94: 21-25.
4. Mestman JH (1997) Hyperthyroidism in pregnancy. Clin Obstet Gynecol 40: 45-64.
5. Papendieck P, Chiesa A, Prieto L, Gruneiro-Papendieck L (2009) Thyroid disorders of neonates born to mothers with Graves’ disease. J Pediatr Endocrinol Metab 22: 547-553.
6. Krassas GE, Poppe K, Glinoer D (2010) Thyroid function and human reproductive health. Endocr Rev 31: 702-755.
7. Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG (1989) Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 160: 63-70.
8. Mandel SJ, Cooper DS (2001) The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 86: 2354-2359.
9. Azizi F (2006) The safety and efficacy of antithyroid drugs. Expert Opin Drug Saf 5: 107-116.
10. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, et al. (2011) American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21: 1081-1125.
11. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, et al. (2012) Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 97: 2543-2565.
12. Poppe K, Hubalewska-Dydejczyk A, Laurberg P, Negro R, Vermiglio F, et al. (2012) Management of Hyperthyroidism in Pregnancy: Results of a Survey among Members of the European Thyroid Association. Eur Thyroid J 1: 34-40.
13. Alamdari S, Azizi F, Delshad H, Sarvghadi F, Amouzegar A, et al. (2013) Management of hyperthyroidism in pregnancy: comparison of recommendations of American thyroid association and endocrine society. J Thyroid Res 2013: Article ID: 878467.
14. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, et al. (1999) Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 83: 43-46.
15. Barbero P, Valdez R, Rodríguez H, Tiscornia C, Mansilla E, et al. (2008) Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet A 146A: 2390-2395.
16. Clemanti M, Di Gianantonio, E, Cassina M, Leoncini E, Botto LD, et al (2010) SAFE-Med study Group. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab 95: E337-341.
17. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P (2004) Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 10: 1018-1023.
18. Bahn RS, Burch HS, Cooper DS, Garber JR, Greenlee CM, et al. (2009) The Role of Propylthiouracil in the Management of Graves’ Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 19: 673-674.
19. Laurberg P, Bournaud C, Karmisholt J, Orgiazzi J (2009) Management of Graves’ hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 160: 1-8.
20. Atkinson S, McGregor AM, Kendall-Taylor P, Peterson MM, Smith BR (1982) Effect of radioiodine on stimulatory activity of Graves’ immunoglobulins. Clin Endocrinol (Oxf) 16: 537-543.
21. Teng CS, Yeung RT, Khoo RK, Alagaratnam TT (1980) A prospective study of the changes in thyrotropin binding inhibitory immunoglobulins in Graves’ disease treated by subtotal thyroidectomy or radioactive iodine. J Clin Endocrinol Metab 50: 1005-1010.
22. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, et al. (2008) TSH-receptor autoimmunity in Graves’ disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 158: 69-75.
23. Hamburger JI (1992) Diagnosis and management of Graves’ disease in pregnancy. Thyroid 2: 219-224.
24. Ochoa-Maya MR, Frates MC, Lee-Parritz A, Seely EW (1999) Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves’ hyperthyroidism. Thyroid 9: 1111-1114.
25. Lee RH, Spencer CA, Mestman JH, Miller EA, Petrovic I, et al. (2009) Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol 200: 260.
26. Anckaert E, Poppe K, Van Uytfanghe K, Schiettecatte J, Foulon W, et al. (2010) FT4 immunoassays may display a pattern during pregnancy similar to the equilibrium dialysis ID-LC/tandem MS candidate reference measurement procedure in spite of susceptibility towards binding protein alterations. Clin Chim Acta 411: 1348-1353.
27. Goodwin TM, Montoro M, Mestman JH (1992) Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 167: 648-652.
28. Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG (2005) Hyperemesis gravidarum, a literature review. Hum Reprod Update 11: 527-239.
29. Bouillon R, Naesens M, Van Assche FA, De Keyser L, De Moor P, et al. (1982) Thyroid function in patients with hyperemesis gravidarum. Am J Obstet Gynecol 143: 922-926.
30. McKenzie JM, Zakarija M (1992) Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 2: 155-159.
31. Mitsuda N, Tamaki H, Amino N, Hosono T, Miyai K, et al. (1992) Risk factors for developmental disorders in infants born to women with Graves disease. Obstet Gynecol 80: 359-364.
32. Peleg D, Cada S, Peleg A, Ben-Ami M (2002) The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstet Gynecol 99: 1040-1043.
33. Zimmerman D (1999) Fetal and neonatal hyperthyroidism. Thyroid 9: 727-733.
34. Polak M, Le Gac I, Vuillard E, Guibourdenche J, Leger J, et al. (2004) Fetal and neonatal thyroid function in relation to maternal Graves’ disease. Best Pract Res Clin Endocrinol Metab 18: 289-302.
35. Cohen O, Pinhas-Hamiel O, Sivan E, Dolitski M, Lipitz S, et al. (2003) Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy. Prenat Diagn 23: 740-742.
36. Azizi F, Hedayati M (2002) Thyroid function in breastfed infants whose mothers take high doses of methimazole. J Endocrinol Invest 25: 493-496.
37. Azizi F, Bahrainian M, Khamseh ME, Khoshniat M (2003) Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole. J Pediatr Endocrinol Metab 16: 1239-1243.